Φορτώνει......
Molecular targeted therapy of BRAF-mutant colorectal cancer
Over the past two decades, the molecular characterization of metastatic colorectal cancer (mCRC) has been revolutionized by the routine implementation of RAS and BRAF tests. As a result, it is now known that patients with mCRC harboring BRAF mutations experience a poor prognosis. Although it account...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Ther Adv Med Oncol |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
SAGE Publications
2019
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6582307/ https://ncbi.nlm.nih.gov/pubmed/31244912 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758835919856494 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|